Does PEMBROLIZUMAB Cause Diffuse alveolar damage? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Diffuse alveolar damage have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.0% of all adverse event reports for PEMBROLIZUMAB.
21
Reports of Diffuse alveolar damage with PEMBROLIZUMAB
0.0%
of all PEMBROLIZUMAB reports
11
Deaths
13
Hospitalizations
How Dangerous Is Diffuse alveolar damage From PEMBROLIZUMAB?
Of the 21 reports, 11 (52.4%) resulted in death, 13 (61.9%) required hospitalization, and 8 (38.1%) were considered life-threatening.
Is Diffuse alveolar damage Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEMBROLIZUMAB. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Diffuse alveolar damage?
METHYLPREDNISOLONE (135)
CYCLOPHOSPHAMIDE (125)
PREDNISONE (122)
METHOTREXATE (112)
DEXAMETHASONE (84)
VINCRISTINE (78)
CYTARABINE (76)
DAUNORUBICIN (75)
ETOPOSIDE (73)
LEUCOVORIN (73)
Which PEMBROLIZUMAB Alternatives Have Lower Diffuse alveolar damage Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G